PACB vs. OKLO

Last updated Apr 1, 2026

Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and Oklo Inc. (OKLO).

Performance

PACB vs. OKLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pacific Biosciences of California, Inc. (PACB) and Oklo Inc. (OKLO). The values are adjusted to include any dividend payments, if applicable.

PACB vs. OKLO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PACB Pacific Biosciences of California, Inc.	-29.41%	2.19%	-81.35%	19.93%	-60.02%	-34.70%
OKLO Oklo Inc.	-30.89%	238.01%	101.04%	6.45%	0.71%	-1.30%

Fundamentals

Market Cap PACB : $398.52M OKLO : $7.26B
EPS PACB : -$1.82 OKLO : -$0.73
PB Ratio PACB : 74.50 OKLO : 4.92
Total Revenue (TTM) PACB : $160.01M OKLO : $0.00
Gross Profit (TTM) PACB : $50.67M OKLO : $0.00
EBITDA (TTM) PACB : -$161.03M OKLO : -$138.92M

Returns By Period

In the year-to-date period, PACB achieves a -29.41% return, which is significantly higher than OKLO's -30.89% return.

PACB

• 1D: 4.76%
• 1M: -21.43%
• YTD: -29.41%
• 6M: 3.13%
• 1Y: 11.86%
• 3Y*: -51.51%
• 5Y*: -47.73%
• 10Y*: -17.78%

OKLO

• 1D: 8.80%
• 1M: -21.22%
• YTD: -30.89%
• 6M: -55.58%
• 1Y: 129.26%
• 3Y*: 69.68%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PACB vs. OKLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PACB

PACB Risk / Return Rank: 50
PACB Sharpe Ratio Rank: 47
PACB Sortino Ratio Rank: 55
PACB Omega Ratio Rank: 49
PACB Calmar Ratio Rank: 49
PACB Martin Ratio Rank: 49

OKLO

OKLO Risk / Return Rank: 76
OKLO Sharpe Ratio Rank: 80
OKLO Sortino Ratio Rank: 83
OKLO Omega Ratio Rank: 75
OKLO Calmar Ratio Rank: 74
OKLO Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PACB vs. OKLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and Oklo Inc. (OKLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PACB	OKLO	Difference
Sharpe ratio Return per unit of total volatility	0.13	1.21	-1.08
Sortino ratio Return per unit of downside risk	0.96	2.21	-1.25
Omega ratio Gain probability vs. loss probability	1.10	1.24	-0.15
Calmar ratio Return relative to maximum drawdown	0.30	1.65	-1.35
Martin ratio Return relative to average drawdown	0.63	3.39	-2.75
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PACB vs. OKLO - Sharpe Ratio Comparison

The current PACB Sharpe Ratio is 0.13, which is lower than the OKLO Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of PACB and OKLO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PACB	OKLO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.13	1.21	-1.08
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.51	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.21	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.18	0.48	-0.66

Correlation

The correlation between PACB and OKLO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PACB vs. OKLO - Dividend Comparison

Neither PACB nor OKLO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PACB vs. OKLO - Drawdown Comparison

The maximum PACB drawdown since its inception was -98.22%, which is greater than OKLO's maximum drawdown of -73.83%. Use the drawdown chart below to compare losses from any high point for PACB and OKLO.

Drawdown Indicators

	PACB	OKLO	Difference
Max Drawdown Largest peak-to-trough decline	-98.22%	-73.83%	-24.39%
Max Drawdown (1Y) Largest decline over 1 year	-52.81%	-73.83%	+21.02%
Max Drawdown (5Y) Largest decline over 5 years	-97.47%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-98.22%	—	—
Current Drawdown Current decline from peak	-97.42%	-71.52%	-25.90%
Average Drawdown Average peak-to-trough decline	-70.20%	-16.20%	-54.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.93%	35.87%	-10.94%

Volatility

PACB vs. OKLO - Volatility Comparison

The current volatility for Pacific Biosciences of California, Inc. (PACB) is 19.48%, while Oklo Inc. (OKLO) has a volatility of 21.29%. This indicates that PACB experiences smaller price fluctuations and is considered to be less risky than OKLO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PACB	OKLO	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.48%	21.29%	-1.81%
Volatility (6M) Calculated over the trailing 6-month period	66.55%	70.69%	-4.14%
Volatility (1Y) Calculated over the trailing 1-year period	91.97%	107.15%	-15.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	93.91%	84.92%	+8.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	84.47%	84.92%	-0.45%

Financials